Form 4: Edwards Lifesciences Executive Daveen Chopra Reports Stock Disposals

Daveen Chopra, a CVP at Edwards Lifesciences, reported the disposal of common stock on May 3rd and 4th, 2025, to cover tax obligations.

Summary

• Daveen Chopra, a CVP at Edwards Lifesciences, filed a Form 4 detailing changes in beneficial ownership.
• The report indicates the disposal of 291 shares of common stock on May 3, 2025, and 289 shares on May 4, 2025, at a price of $75.65 per share.
• These transactions were likely to cover tax obligations related to equity compensation.
• Following these transactions, Chopra directly owns 27,003 shares of Edwards Lifesciences common stock.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock disposals, likely for tax purposes, and doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely monitored by investors to gauge management's sentiment and potential future performance.

Stakeholder Impact

• The stock disposal has a minimal impact on shareholders as it is a small percentage of the total outstanding shares.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Disposal, Edwards Lifesciences, Daveen Chopra, Equity Compensation, TMTT